Lyka Labs informs about update on scheme of amalgamation

25 Nov 2023 Evaluate
With reference to previous intimation made through a letter dated October 13, 2023 wherein the Company has confirmed the filing of a joint application ('Joint Application') by Lyka Exports (the 'Transferor Company') and Lyka Labs (the 'Transferee Company') with the Hon'ble National Company Law Tribunal, Ahmedabad Bench ('NCLT') in the matter of Scheme of Amalgamation of Lyka Exports and Lyka Labs under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 read with the applicable Rules and which meets the compliance of Regulation 37 of the SEBI (LODR) Regulations, 2015, Lyka Labs has informed that based on the aforesaid Joint Application, the order dated 24th November 2023 as pronounced by the Hon'ble NCLT (the 'Order'), has been uploaded on the website of the NCLT. The Order has been uploaded on the NCLT website on 24th November 2023. The Company has observed a typo error in the Order regarding consideration pursuant to the Scheme, for which we will be approaching the NCLT appropriately. This intimation shall also be available on the Company website.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

105.60 -2.30 (-2.13%)
03-Jun-2024 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1453.25
Dr. Reddys Lab 5792.95
Cipla 1459.85
Zydus Lifesciences 1032.25
Lupin 1583.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.